ZOM logo

Zomedica (ZOM) EBITDA

Annual EBITDA

-$29.39 M
-$14.05 M-91.60%

December 31, 2023

Summary

Performance

1-Year Change

-91.6%

3-Year Change

-79.4%

5-Year Change

-78.73%

15-Year Change

-267.72%

ZOM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

43.93%
ZOM annual EBITDA is higher than 43.93% of companies in Healthcare sector

High & Low

All-time High

-$42.40 K

3-Year Low

-$29.39 M
ZOM annual EBITDA is currently at its 3-year low

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
ZOM previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Apr 1, 2025
ZOM next annual earnings announcement is scheduled for Apr 1, 2025

OtherZOMprofitabilitymetrics:

Annual Revenue

$25.19 M
ZOM annual revenue is $25.19 million

Annual Net Income

-$34.53 M
ZOM annual net profit is -$34.53 million

Annual EBIT

-$35.69 M
ZOM annual earnings before interest & taxes is -$35.69 million

Annual EPS

-$0.04
ZOM annual earnings per share is -$0.04

Quarterly EBITDA

-$4.70 M
+$17.40 M+78.75%

September 30, 2024

Summary

Performance

3-Month Change

+78.75%

1-Year Change

+36.5%

3-Year Change

-78.9%

5-Year Change

-78.9%

ZOM Quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

48.64%
ZOM quarterly EBITDA is higher than 48.64% of companies in Healthcare sector

High & Low

All-time High

-$2400.00

3-Year Low

-$22.10 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZOM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
ZOM next earnings announcement is scheduled for Apr 1, 2025

OtherZOMprofitabilitymetrics:

Quarterly Revenue

$7.00 M
ZOM quarterly revenue is $7.00 million

Quarterly Net Income

-$6.70 M
ZOM quarterly net profit is -$6.70 million

Quarterly EBIT

-$6.72 M
ZOM quarterly earnings before interest & taxes is -$6.72 million

Quarterly EPS

-$0.01
ZOM quarterly earnings per share is -$0.01

TTM EBITDA

-$54.27 M
-$3.94 M-7.84%

September 30, 2024

Summary

Performance

3-Month Change

-7.84%

1-Year Change

-69.48%

3-Year Change

-253.82%

5-Year Change

-253.82%

ZOM TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

30.17%
ZOM TTM EBITDA is higher than 30.17% of companies in Healthcare sector

High & Low

All-time High

-$14.50 K

3-Year Low

-$54.27 M
ZOM TTM EBITDA is currently at its 3-year low

Earnings dates

Last Quarterly Earnings Report Date

Sep 30, 2024
ZOM previous earnings announcement was published on Sep 30, 2024

Next Quarterly Earnings Report Date

Apr 1, 2025
ZOM next earnings announcement is scheduled for Apr 1, 2025

OtherZOMprofitabilitymetrics:

TTM Revenue

$26.73 M
ZOM TTM revenue is $26.73 million

TTM Net Income

-$62.19 M
ZOM TTM net profit is -$62.19 million

TTM EBIT

-$62.07 M
ZOM TTM earnings before interest & taxes is -$62.07 million

TTM EPS

-$0.07
ZOM TTM earnings per share is -$0.07

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

Annual EBITDA

-$29.39 M
ZOM annual EBITDA is -$29.39 million

Annual Net Income

-$34.53 M
ZOM annual net profit is -$34.53 million

Annual Interest Expense

$175.00 K
ZOM annual interest expense is $175.00 thousand

Annual Income Tax

-$1.33 M
ZOM annual income tax is -$1.33 million

Annual D&A

$6.30 M
ZOM annual depreciation & amortization is $6.30 million

ZOM EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-91.6%+36.5%-69.5%
3 y3 years-79.4%-78.9%-253.8%
5 y5 years-78.7%-78.9%-253.8%

ZOM EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-91.6%at low-525.3%+78.8%-354.7%at low
5 y5-year-91.6%at low-525.3%+78.8%-454.7%at low
alltimeall time<-9999.0%at low<-9999.0%+78.8%<-9999.0%at low

Zomedica EBITDA History

DateAnnualQuarterlyTTM
Sep 2024
-
-$4.70 M(-78.7%)
-$54.27 M(+7.8%)
Jun 2024
-
-$22.10 M(+198.8%)
-$50.32 M(+57.2%)
Mar 2024
-
-$7.39 M(-63.2%)
-$32.02 M(+9.0%)
Dec 2023
-$29.39 M(+91.6%)
-$20.08 M(+2573.4%)
-$29.39 M(+146.2%)
Sep 2023
-
-$751.00 K(-80.2%)
-$11.94 M(-23.9%)
Jun 2023
-
-$3.79 M(-20.3%)
-$15.68 M(-6.1%)
Mar 2023
-
-$4.76 M(+81.5%)
-$16.70 M(+8.9%)
Dec 2022
-$15.34 M(-21.6%)
-$2.63 M(-41.6%)
-$15.34 M(-9.7%)
Sep 2022
-
-$4.50 M(-6.6%)
-$16.99 M(-9.6%)
Jun 2022
-
-$4.82 M(+41.9%)
-$18.79 M(-2.1%)
Mar 2022
-
-$3.40 M(-20.5%)
-$19.20 M(-1.9%)
Dec 2021
-$19.57 M(+19.5%)
-$4.27 M(-32.2%)
-$19.57 M(+1.1%)
Sep 2021
-
-$6.30 M(+20.5%)
-$19.35 M(+8.1%)
Jun 2021
-
-$5.23 M(+38.7%)
-$17.91 M(+0.2%)
Mar 2021
-
-$3.77 M(-7.0%)
-$17.86 M(+9.1%)
Dec 2020
-$16.38 M(-13.7%)
-$4.05 M(-16.5%)
-$16.38 M(+9.3%)
Sep 2020
-
-$4.86 M(-6.3%)
-$14.98 M(+17.3%)
Jun 2020
-
-$5.19 M(+126.8%)
-$12.77 M(+30.6%)
Mar 2020
-
-$2.29 M(-13.8%)
-$9.78 M(-48.5%)
Dec 2019
-$18.98 M(+15.4%)
-$2.65 M(+0.2%)
-$18.98 M(-23.1%)
Sep 2019
-
-$2.65 M(+20.6%)
-$24.69 M(+3.5%)
Jun 2019
-
-$2.20 M(-80.9%)
-$23.87 M(-7.4%)
Mar 2019
-
-$11.48 M(+37.2%)
-$25.79 M(+56.9%)
Dec 2018
-$16.44 M
-$8.37 M(+358.8%)
-$16.44 M(+55.0%)
DateAnnualQuarterlyTTM
Sep 2018
-
-$1.82 M(-55.7%)
-$10.61 M(-2.2%)
Jun 2018
-
-$4.12 M(+92.9%)
-$10.85 M(+30.7%)
Mar 2018
-
-$2.13 M(-15.9%)
-$8.30 M(+3.9%)
Dec 2017
-$7.99 M(+40.7%)
-$2.54 M(+23.0%)
-$7.99 M(-1.7%)
Sep 2017
-
-$2.06 M(+31.6%)
-$8.13 M(+14.6%)
Jun 2017
-
-$1.57 M(-14.1%)
-$7.09 M(+7.7%)
Mar 2017
-
-$1.82 M(-31.8%)
-$6.59 M(+37.9%)
Dec 2016
-$5.68 M(>+9900.0%)
-$2.68 M(+160.5%)
-$4.78 M(+124.7%)
Sep 2016
-
-$1.03 M(-3.0%)
-$2.13 M(+92.7%)
Jun 2016
-
-$1.06 M(+6688.5%)
-$1.10 M(+1891.5%)
Feb 2016
-
-$15.60 K(-34.7%)
-$55.40 K(0.0%)
Feb 2016
-$54.50 K(-96.4%)
-
-
Dec 2015
-$1.52 M(+3481.8%)
-
-
Nov 2015
-
-$23.90 K(+397.9%)
-$55.40 K(+37.5%)
Aug 2015
-
-$4800.00(-56.8%)
-$40.30 K(-13.5%)
May 2015
-
-$11.10 K(-28.8%)
-$46.60 K(+7.4%)
Feb 2015
-
-$15.60 K(+77.3%)
-$43.40 K(+43.7%)
Feb 2015
-$42.40 K(-45.3%)
-
-
Nov 2014
-
-$8800.00(-20.7%)
-$30.20 K(-60.1%)
Aug 2014
-
-$11.10 K(+40.5%)
-$75.60 K(+5.9%)
May 2014
-
-$7900.00(+229.2%)
-$71.40 K(-8.5%)
Feb 2014
-$77.50 K
-$2400.00(-95.6%)
-$78.00 K(+3.2%)
Nov 2013
-
-$54.20 K(+685.5%)
-$75.60 K(+253.3%)
Aug 2013
-
-$6900.00(-52.4%)
-$21.40 K(+47.6%)
May 2013
-
-$14.50 K
-$14.50 K

FAQ

  • What is Zomedica annual EBITDA?
  • What is the all time high annual EBITDA for Zomedica?
  • What is Zomedica annual EBITDA year-on-year change?
  • What is Zomedica quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Zomedica?
  • What is Zomedica quarterly EBITDA year-on-year change?
  • What is Zomedica TTM EBITDA?
  • What is the all time high TTM EBITDA for Zomedica?
  • What is Zomedica TTM EBITDA year-on-year change?

What is Zomedica annual EBITDA?

The current annual EBITDA of ZOM is -$29.39 M

What is the all time high annual EBITDA for Zomedica?

Zomedica all-time high annual EBITDA is -$42.40 K

What is Zomedica annual EBITDA year-on-year change?

Over the past year, ZOM annual EBITDA has changed by -$14.05 M (-91.60%)

What is Zomedica quarterly EBITDA?

The current quarterly EBITDA of ZOM is -$4.70 M

What is the all time high quarterly EBITDA for Zomedica?

Zomedica all-time high quarterly EBITDA is -$2400.00

What is Zomedica quarterly EBITDA year-on-year change?

Over the past year, ZOM quarterly EBITDA has changed by +$2.70 M (+36.50%)

What is Zomedica TTM EBITDA?

The current TTM EBITDA of ZOM is -$54.27 M

What is the all time high TTM EBITDA for Zomedica?

Zomedica all-time high TTM EBITDA is -$14.50 K

What is Zomedica TTM EBITDA year-on-year change?

Over the past year, ZOM TTM EBITDA has changed by -$22.25 M (-69.48%)